ESS
37
-2
KSS
62
2
KO
44
-2
MSI
50
3
ROP
50
3
MAC
62
2
FIS
56
3
NTAP
67
2
EIX
53
6
LEN
40
2
RL
83
7
APD
52
-2
MET
60
2
ZBH
47
-9
MMC
55
-2
EMC
60
2
PG
53
-2
LOW
62
4
FITB
73
-2
D
37
-6
ESS
37
-2
KSS
62
2
KO
44
-2
MSI
50
3
ROP
50
3
MAC
62
2
FIS
56
3
NTAP
67
2
EIX
53
6
LEN
40
2
RL
83
7
APD
52
-2
MET
60
2
ZBH
47
-9
MMC
55
-2
EMC
60
2
PG
53
-2
LOW
62
4
FITB
73
-2
D
37
-6
Financhill
Back

Dr. Reddy's Laboratories Ltd. 10K Form

Buy
55

RDY
Dr. Reddy's Laboratories Ltd.

Last Price:
$14.20
Seasonality Move:
4.97%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RDY News And Ratings

See the #1 stock for the next 7 days that we like better than RDY

RDY Financial Statistics

Sales & Book Value

Annual Sales: $3.9B
Cash Flow: $49.2M
Price / Cash Flow: 68.29
Annual Sales: $4.84
Price / Book: 2.93

Profitability

EPS (TTM): 0.81680
Net Income (TTM): $677.6M
Gross Margin: $2.1B
Return on Equity: 17.11%
Return on Assets: 11.54%

Dr. Reddy's Laboratories Ltd. Earnings Forecast

Key Dr. Reddy's Laboratories Ltd. Financial Ratios

  • The Gross Profit Margin over the past 32 years for RDY is 55.44%.
  • The Selling, General & Administrative Expenses for RDY have been equal to 28.84% of Gross Profit Margin.
  • The Research & Development expenses have been 8.00% of Revenue.
  • The Interest Expense is 4.94% of Operating Income.
  • The Net Earning history of RDY is 17.58% of Total Revenues.
  • Per Share Earnings over the last 32 years have been positive in 19 years.

Dr. Reddy's Laboratories Ltd. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: RDY
CUSIP: 256135
Website: drreddys.com

Debt

Debt-to-Equity Ratio: 0.16
Current Ratio: 1.85
Quick Ratio: 1.12

Price-to-Earnings

Trailing P/E Ratio: 17.7
Forward P/E Ratio: 22

RDY Technical Analysis vs Fundamental Analysis

Buy
55
Dr. Reddy's Laboratories Ltd. (RDY) is a Buy

Is Dr. Reddy's Laboratories Ltd. a Buy or a Sell?